<DOC>
	<DOCNO>NCT00156624</DOCNO>
	<brief_summary>The Thunder Trail randomize , double-blinded , placebo controlled German multi-centre study efficacy local paclitaxel prevention restenosis superficial popliteal artery .</brief_summary>
	<brief_title>Thunder Trial - Local Taxan With Short Time Contact Reduction Restenosis Distal Arteries</brief_title>
	<detailed_description>Drug elute stent proven reduce restenosis rate coronary artery . Unfortunately drug elute stent fail demonstrate superiority bare stents superficial femoral artery . We could show non-stent base delivery Taxan equal superior drug elute stent animal model . This true coronary artery peripheral vessel . In prospective blind trail &gt; 135 patient randomize either receive Taxan locally administer balloon catheter balloon angioplasty , together contrast medium . One group serve control . There limitation due lesion length . Follow-up angiography 6 month , 12 month 2 year .</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Adults Chronic Occlusions stenosis ( history least 6 week ) â‰¥70 % diameter Stenosis &gt; 2cm arteria femoralis superficialis arteria poplitea Various criterion assure ethical issue follow Conditions require different treatment raise serious safety concern regard procedure require medication . Pregnancy exclude Doubts willingness capability patient allow 6 month follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Intervention</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Drug</keyword>
	<keyword>Restenosis</keyword>
	<keyword>18 year</keyword>
</DOC>